Pfizer Inc. (PFE)

• Annual Data
• Quarterly Data

Pfizer Inc., common-size consolidated income statement (quarterly data)

	3 months ended	Sep 29, 2019		Jun 30, 2019		Mar 31, 2019		Dec 31, 2018		Sep 30, 2018		Jul 1, 2018		Apr 1, 2018		Dec 31, 2017		Oct 1, 2017		Jul 2, 2017		Apr 2, 2017		Dec 31, 2016		Oct 2, 2016		Jul 3, 2016		Apr 3, 2016		Dec 31, 2015		Sep 27, 2015		Jun 28, 2015		Mar 29, 2015		Dec 31, 2014		Sep 28, 2014		Jun 29, 2014		Mar 30, 2014
	Revenues
	Cost of sales
	Gross profit
	Selling, informational and administrative expenses
	Research and development expenses
	Amortization of intangible assets
	Restructuring charges and certain acquisition-related costs
	Operating income
	Gain on completion of Consumer Healthcare JV transaction
	Other income (deductions), net
	Income from continuing operations before provision for taxes on income
	(Provision) benefit for taxes on income
	Income from continuing operations
	Discontinued operations, net of tax
	Net income before allocation to noncontrolling interests
	Net income attributable to noncontrolling interests
	Net income attributable to Pfizer Inc.
	Preferred stock dividends, net of tax
	Net income attributable to Pfizer Inc. common shareholders

Based on: 10-Q (filing date: 2019-11-07), 10-Q (filing date: 2019-08-08), 10-Q (filing date: 2019-05-09), 10-K (filing date: 2019-02-28), 10-Q (filing date: 2018-11-08), 10-Q (filing date: 2018-08-09), 10-Q (filing date: 2018-05-10), 10-K (filing date: 2018-02-22), 10-Q (filing date: 2017-11-09), 10-Q (filing date: 2017-08-10), 10-Q (filing date: 2017-05-11), 10-K (filing date: 2017-02-23), 10-Q (filing date: 2016-11-10), 10-Q (filing date: 2016-08-11), 10-Q (filing date: 2016-05-12), 10-K (filing date: 2016-02-29), 10-Q (filing date: 2015-11-05), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-07), 10-K (filing date: 2015-02-27), 10-Q (filing date: 2014-11-06), 10-Q (filing date: 2014-08-07), 10-Q (filing date: 2014-05-08).